跳至主要内容
临床试验/IRCT20210623051676N1
IRCT20210623051676N1招募中2 期

Determination of the pathological response of localized or locally advanced esophageal carcinoma to induction chemotherapy and concurrent chemotherapy with hypofractionated radiotherapy before surgery.

Mashhad University of Medical Sciences0 个研究点目标入组 43 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • carcinoma in thoracic or abdominal esophagus
  • performance status above or equal to 70% in karnofsky criteria or less or equal to 1 in ECOG criteria
  • presence of 3rd grade or more dysphasia or disease in T2-T4 N0 M0 or any T N+ M0 stage
  • consent to the whole treatment program including surgery

排除标准

  • presence of metastatic disease
  • presence of cervical esophagus
  • invasion to heart, trachea, bronchus or aorta
  • dissent to surgery
  • history of cancer or other diseases that interfere to complete the treatment program

研究者

相似试验